Corbus appoints Craig Millian as Chief Operating Officer, effective Sept 27

Corbus Pharmaceuticals Holdings, Inc.

Craig Millian appointed COO effective Sept 27, 2021; previously served as Chief Commercial Officer since Feb 2019.
Amendment to employment agreement confirms role change does not constitute 'Good Reason' for termination.
Mr. Millian's base salary remains $400,000, eligible for annual bonus up to 40% of base salary.
He brings 25 years of pharmaceutical commercial experience from EMD Serono, Vertex, Pfizer, and Sanofi.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Craig Millian

Chief Operating Officer

CRBP · Corbus Pharmaceuticals Holdings, Inc.

Filed: September 28, 2021, 7:59 PM ET

On September 24, 2021, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Craig Millian as Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Craig Millian was appointed as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On September 24, 2021, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Craig Millian as Chief Operating Officer.

View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-023935

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.